Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.17
-0.15 (-1.61%)
At close: Jul 24, 2026, 4:00 PM EDT
9.18
+0.01 (0.11%)
After-hours: Jul 24, 2026, 7:34 PM EDT
CRBP Market Cap
CRBP has a market cap or net worth of $169.9 million as of July 24, 2026. Its market cap has increased by 57.90% in one year.
Market Cap
169.90M
Enterprise Value
32.89M
1-Year Change
57.90%
Ranking
Category
Stock Price
$9.17
ChartMarket Cap Chart
Since November 11, 2014, CRBP's market cap has increased from $75.80M to $169.90M, an increase of 124.14%. That is a compound annual growth rate of 7.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 169.90M | 18.89% |
| Dec 31, 2025 | 142.90M | -0.56% |
| Dec 31, 2024 | 143.70M | 438.20% |
| Dec 29, 2023 | 26.70M | 93.48% |
| Dec 30, 2022 | 13.80M | -82.10% |
| Dec 31, 2021 | 77.10M | -26.57% |
| Dec 31, 2020 | 105.00M | -70.26% |
| Dec 31, 2019 | 353.10M | 5.62% |
| Dec 31, 2018 | 334.30M | -14.19% |
| Dec 29, 2017 | 389.60M | 3.75% |
| Dec 30, 2016 | 375.50M | 505.65% |
| Dec 31, 2015 | 62.00M | -19.58% |
| Dec 31, 2014 | 77.10M | 1.72% |
| Nov 11, 2014 | 75.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 177.89M |
| AN2 Therapeutics | 177.20M |
| NRx Pharmaceuticals | 172.25M |
| Humacyte | 172.19M |
| OnKure Therapeutics | 170.47M |
| Oramed Pharmaceuticals | 170.25M |
| Equillium | 170.08M |
| Pyxis Oncology | 169.79M |